Can rapamycin be the key to unlocking a longer, healthier life? Join us as Krister Kauppi, a dedicated health and longevity enthusiast, shares his captivating journey from a personal health scare to discovering the potential of rapamycin as an alternative to intermittent fasting. We delve into the science behind this intriguing compound, focusing on how it inhibits mTOR and activates catabolic processes, potentially slowing down aging and reducing the incidence of age-related diseases. Together, we explore the delicate balance between anabolic and catabolic processes and the significant roles that insulin, insulin-like growth factor, and testosterone play in these pathways.

Krister also opens up about his personal experiences with rapamycin, highlighting the crucial importance of personalized dosages and the remarkable benefits he observed, such as improved dental health and reduced inflammation. We discuss the exciting concept of longevity cocktails—combinations of fasting, rapamycin, and other interventions aimed at extending lifespan. Learn about the innovative work being done at the Rapamycin Longevity Lab and their mission to create advanced longevity solutions, leveraging cutting-edge technology like Ora Biomedical's WormBot. This episode is a compelling invitation to join us on a groundbreaking journey towards enhancing human longevity.

https://masteronething.com/
https://www.linkedin.com/in/krister-kauppi/recent-activity/all/

Continue this conversation on SubStack: https://robertlufkinmd.substack.com 

Lies I Taught In Medical School : Free sample chapter- https://www.robertlufkinmd.com/lies/

Web: https://robertlufkinmd.com/
X: https://x.com/robertlufkinmd
Youtube: https://www.youtube.com/robertLufkinmd
Instagram: https://www.instagram.com/robertlufkinmd/
LinkedIn: https://www.linkedin.com/in/robertlufkinmd/
TikTok: https://www.tiktok.com/@robertlufkin
Threads: https://www.threads.net/@robertlufkinmd
Facebook: https://www.facebook.com/robertlufkinmd
Bluesky: https://bsky.app/profile/robertlufkinmd.bsky.social
Mastodon: ...